The global ulcerated necrobiosis lipoidica management market is poised for significant growth, with an anticipated valuation of US$ 4.4 billion in 2023. According to recent industry analysis, the market is projected to expand at a compound annual growth rate (CAGR) of 6.03%, reaching an impressive US$ 7.9 billion by 2033. Ulcerated necrobiosis lipoidica, a rare …